These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 8638310)

  • 21. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma.
    Nielsen LP; Dahl R
    Am J Respir Crit Care Med; 2000 Jun; 161(6):2114-5. PubMed ID: 10852798
    [No Abstract]   [Full Text] [Related]  

  • 22. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate.
    Todd G; Dunlop K; McNaboe J; Ryan MF; Carson D; Shields MD
    Lancet; 1996 Jul; 348(9019):27-9. PubMed ID: 8691927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The problem of dose-response and therapeutic ratio of inhaled steroids.
    Lipworth BJ
    Am J Respir Crit Care Med; 2001 Jun; 163(7):1758; author reply 1759. PubMed ID: 11401902
    [No Abstract]   [Full Text] [Related]  

  • 24. Adrenal suppression with inhaled corticosteroids.
    Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Nov; 87(5):359-61. PubMed ID: 11730176
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhaled fluticasone in asthmatic children.
    Pescollderungg L; Radetti G; Gottardi E; Gentili L; Pietrobelli A; Boner AL
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):328-9; author reply 329. PubMed ID: 12269658
    [No Abstract]   [Full Text] [Related]  

  • 26. Starting inhaled corticosteroids in asthma: when, how high, and how long.
    van der Molen T; Kerstjens HA
    Eur Respir J; 2000 Jan; 15(1):3-4. PubMed ID: 10678612
    [No Abstract]   [Full Text] [Related]  

  • 27. Newer therapeutic agents for asthma.
    Deykin A; Israel E
    Adv Intern Med; 1999; 44():209-37. PubMed ID: 9929710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Initial treatment of symptomatic mild to moderate bronchial asthma with the salmeterol/fluticasone propionate (50/250 microg) combination product (SAS 40023).
    Baumgarten C; Geldszus R; Behre U; Peslis N; Trautmann M;
    Eur J Med Res; 2002 Jan; 7(1):1-7. PubMed ID: 11827834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Fluticasone propionate in children and infants with asthma].
    Marchac V; Foussier V; Devillier P; Le Bourgeois M; Polak M
    Arch Pediatr; 2007 Apr; 14(4):376-87. PubMed ID: 17289359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Asthma and Cushing's syndrome.
    Wilson AM; Blumsohn A; Jung RT; Lipworth BJ
    Chest; 2000 Feb; 117(2):593-4. PubMed ID: 10669710
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth failure due to inhaled corticosteroid therapy.
    Kumah-Crystal Y; Lomenick JP
    Clin Pediatr (Phila); 2011 Feb; 50(2):159-61. PubMed ID: 20837620
    [No Abstract]   [Full Text] [Related]  

  • 32. Steroid naive eosinophilic asthma: anti-inflammatory effects of fluticasone and montelukast.
    Jayaram L; Pizzichini E; Lemière C; Man SF; Cartier A; Hargreave FE; Pizzichini MM
    Thorax; 2005 Feb; 60(2):100-5. PubMed ID: 15681495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [An evaluation of the acceptance of budesonide turbuhaler by older Japanese patients with bronchial asthma when changed from fluticasone propionate (FP) or beclomethasone dipropionate (BDP)].
    Ohbayashi H; Yamase H
    Arerugi; 2003 Jan; 52(1):31-8. PubMed ID: 12598720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal insufficiency after treatment with fluticasone. Data on fluticasone are reassuring but what about doctors' prescribing?
    Pescollderungg L; Pietrobelli A; Boner AL
    BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12378731
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bronchial asthma. Fluticasone propionate, a new inhalational corticosteroid defines new reference standards. "Advancing Corticosteroid Therapy" Symposium, Amsterdam, 6 May 1994].
    Fortschr Med Suppl; 1995; 167():1-14. PubMed ID: 7749661
    [No Abstract]   [Full Text] [Related]  

  • 36. [Peak inspiratory flow rates attained by asthmatic patients through a dry-powder inhaler of fluticasone propionate].
    Fujimori K; Suzuki E; Gejyo F
    Arerugi; 2001 Jun; 50(6):551-4. PubMed ID: 11517519
    [No Abstract]   [Full Text] [Related]  

  • 37. [Perioral dermatitis in children under steroid inhalation therapy].
    Held E; Ottevanger V; Petersen CS; Weismann K
    Ugeskr Laeger; 1997 Nov; 159(47):7002-3. PubMed ID: 9417708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of Azmacort MDI and Flovent Diskhaler.
    Deslandes B; Lim J; Staudinger H
    J Allergy Clin Immunol; 1998 Jul; 102(1):154-5. PubMed ID: 9679864
    [No Abstract]   [Full Text] [Related]  

  • 39. [Asthma, steroid inhalation and growth].
    Bjerknes R; Skadberg B; Njølstad PR
    Tidsskr Nor Laegeforen; 2001 Jan; 121(3):281. PubMed ID: 11242865
    [No Abstract]   [Full Text] [Related]  

  • 40. Adrenal insufficiency after treatment with fluticasone. Dose-response curve should have been highlighted.
    Mohamed ASh
    BMJ; 2002 Oct; 325(7368):836; author reply 836. PubMed ID: 12378732
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.